Edwards Lifesciences

Edwards Lifesciences is a medical device company specialaining in structural heart disease. It develops, manufactures and markets artificial heart valves and hemodynamic monitoring solutions for patients with cardiovascular disease. The company has worked on cardiovascular technologies for over 65 years and now serves patients in more than 100 countries.

Its portfolio includes artificial heart valves and hemodynamic monitoring solutions, as well as Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Heart Valve (THV) devices. TAVR allows heart valve replacement without open-heart surgery. The technology was developed in partnership with cardiologists and clinical teams and is supported by rigorous clinical evidence. Work spans structural heart innovation, cardiovascular medical devices, artificial heart valve technology, transcatheter aortic valve replacement and hemodynamic monitoring, with device development grounded in clinical evidence.

The company operates across the medical device, cardiovascular care and structural heart disease sectors, addressing the needs of critical cardiac patients and hospital cardiology departments. Its technology teams work on solutions intended for patients many years into the future, with an emphasis on patient-focused innovation and partnership with clinical teams. The stated mission is to help people live longer and healthier lives.